Bioresorvable endovascular patch research project from Institut Químic de Sarrià (IQS) has been awarded one of CaixaImpulse Consolidate grant among the 40 European research projects presented. This programme, promoted by the “La Caixa” Banking Foundation, drives the transformation of scientific knowledge into services, products, or businesses that create value in society.
Our CEO, Dr. Martorell has led this project since 2015 at Vascular Engineering and Applied Biomedicine group at IQS. Along with the rest of the project’s core team: Dr. Riambau, Dr. Borrós, and our CTO Ms. Balà, they are focused on transferring innovative technology applied to vascular diseases.
CaixaImpulse Validate 2017 was the cornerstone to transform this research project into a spin-off, Aortyx, so we expect CaixaImpulse Consolidate to be the cornerstone to reach the clinical stage. This recognition reinforces the research project’s strength and disruptive innovation solution for aortic diseases through the collaboration between IQS and Aortyx.
The 24 months’ fund will be assigned to Non-GLP development to reach a design freeze before starting GLP development towards the clinical experimentation with the First in Human trials. Meanwhile, it will be needed to secure funding IP costs and production.
CaixaImpulse Consolidate, which grants up to 300k€ and mentoring training, will help to continue to fix the patch commercialisation objective in 2024.